| Primary |
| Hypertension |
54.2% |
| Product Used For Unknown Indication |
25.4% |
| Diabetes Mellitus |
2.7% |
| Blood Pressure |
2.6% |
| Pain |
2.1% |
| Aortic Valve Replacement |
1.7% |
| Prophylaxis Against Transplant Rejection |
1.6% |
| Essential Hypertension |
1.4% |
| Proteinuria |
1.2% |
| Atrial Fibrillation |
1.0% |
| Prophylaxis |
0.9% |
| Depression |
0.8% |
| Foetal Exposure During Pregnancy |
0.7% |
| Hyperlipidaemia |
0.7% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Gout |
0.6% |
| Hypercholesterolaemia |
0.6% |
| Type 2 Diabetes Mellitus |
0.6% |
| Arrhythmia |
0.4% |
| Blood Pressure Abnormal |
0.4% |
|
| Product Substitution Issue |
12.7% |
| Angioedema |
10.5% |
| Drug Ineffective |
8.4% |
| Dizziness |
7.3% |
| Blood Pressure Increased |
6.9% |
| Headache |
6.2% |
| Hyperkalaemia |
5.8% |
| Renal Failure Acute |
5.5% |
| Urticaria |
4.7% |
| Hypertension |
4.4% |
| Vomiting |
3.6% |
| Syncope |
3.3% |
| Visual Impairment |
3.3% |
| Convulsion |
2.9% |
| Pemphigoid |
2.9% |
| Dry Eye |
2.5% |
| Dyspnoea |
2.5% |
| Confusional State |
2.2% |
| Cough |
2.2% |
| Myalgia |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
40.9% |
| Hypertension |
26.1% |
| Drug Use For Unknown Indication |
13.5% |
| Atrial Fibrillation |
3.1% |
| Blood Pressure |
2.4% |
| Diabetes Mellitus |
2.2% |
| Pain |
1.4% |
| Aortic Valve Replacement |
1.2% |
| Convulsion |
1.1% |
| Blood Pressure Abnormal |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Rheumatoid Arthritis |
1.0% |
| Hyperuricaemia |
0.7% |
| Hyperlipidaemia |
0.7% |
| Cardiac Failure |
0.6% |
| Prophylaxis |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Prophylaxis Against Transplant Rejection |
0.6% |
| Anaesthesia |
0.5% |
| Depression |
0.5% |
|
| Renal Failure Acute |
14.3% |
| Completed Suicide |
10.3% |
| Hypertension |
8.6% |
| Syncope |
7.0% |
| Hypotension |
5.6% |
| Overdose |
5.3% |
| Blood Pressure Increased |
5.0% |
| Myalgia |
4.7% |
| Vomiting |
4.7% |
| Convulsion |
4.0% |
| Drug Ineffective |
3.7% |
| Oropharyngeal Pain |
3.3% |
| Cutaneous Lupus Erythematosus |
3.0% |
| Dizziness |
3.0% |
| Fatigue |
3.0% |
| Headache |
3.0% |
| Malaise |
3.0% |
| Panic Attack |
3.0% |
| Swollen Tongue |
3.0% |
| Hyperkalaemia |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.7% |
| Hypertension |
19.5% |
| Drug Use For Unknown Indication |
13.7% |
| Rheumatoid Arthritis |
6.0% |
| Diabetes Mellitus |
4.1% |
| Atrial Fibrillation |
2.9% |
| Prophylaxis |
2.9% |
| Pain |
2.4% |
| Blood Cholesterol Increased |
2.4% |
| Type 2 Diabetes Mellitus |
2.3% |
| Blood Pressure |
2.1% |
| Hepatitis C |
1.8% |
| Depression |
1.8% |
| Osteoporosis |
1.8% |
| Cardiac Disorder |
1.7% |
| Asthma |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Multiple Myeloma |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Hypercholesterolaemia |
1.0% |
|
| Vomiting |
10.8% |
| Weight Decreased |
7.4% |
| Drug Ineffective |
5.8% |
| Pneumonia |
5.6% |
| Dyspnoea |
5.4% |
| Nausea |
5.1% |
| Death |
4.9% |
| Fatigue |
4.9% |
| Urinary Tract Infection |
4.7% |
| Diarrhoea |
4.6% |
| Pain |
4.4% |
| Pruritus |
4.3% |
| Flushing |
4.3% |
| Hypertension |
4.3% |
| Myocardial Infarction |
4.3% |
| Headache |
4.1% |
| Renal Failure Acute |
4.0% |
| Rash |
3.9% |
| Pain In Extremity |
3.5% |
| Weight Increased |
3.5% |
|
| Interacting |
| Hypertension |
30.8% |
| Product Used For Unknown Indication |
14.7% |
| Atrial Fibrillation |
7.7% |
| Diabetes Mellitus |
7.7% |
| Convulsion |
5.1% |
| Depression |
5.1% |
| Blood Pressure Abnormal |
3.2% |
| Ingrowing Nail |
3.2% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Pain |
2.6% |
| Asthma |
1.9% |
| Cardiac Failure Chronic |
1.9% |
| Flushing |
1.9% |
| Heart Rate Abnormal |
1.9% |
| Osteoarthritis |
1.9% |
| Prophylaxis |
1.9% |
| Renal Disorder |
1.9% |
| Acute Myocardial Infarction |
1.3% |
| Ascites |
1.3% |
| Atrial Flutter |
1.3% |
|
| Renal Failure Acute |
13.9% |
| Drug Interaction |
11.1% |
| Tricuspid Valve Incompetence |
11.1% |
| Hypotension |
8.3% |
| Headache |
5.6% |
| Hypertension |
5.6% |
| Pain In Extremity |
5.6% |
| Visual Acuity Reduced |
5.6% |
| Bundle Branch Block Left |
2.8% |
| Confusional State |
2.8% |
| Dehydration |
2.8% |
| Dizziness |
2.8% |
| Hypertensive Crisis |
2.8% |
| Hyponatraemia |
2.8% |
| Palpitations |
2.8% |
| Rash Generalised |
2.8% |
| Therapeutic Agent Toxicity |
2.8% |
| Transient Ischaemic Attack |
2.8% |
| Urinary Retention |
2.8% |
| Vomiting |
2.8% |
|
